Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signaling
- PMID: 25588018
- DOI: 10.4414/smw.2015.14043
Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signaling
Abstract
Novel psychoactive substances are newly used designer drugs ("internet drugs", "research chemicals", "legal highs") potentially posing similar health risks to classic illicit substances. Chemically, many novel psychoactive substances can be classified as phenethylamines, amphetamines, synthetic cathinones, piperazines, pipradrols/piperidines, aminoindanes benzofurans, and tryptamines. Pharmacologically, these substances interact with various monoaminergic targets. Typically, stimulants inhibit the transport of dopamine and noradrenaline (pipradrols, pyrovalerone cathinones) or induce the release of these monoamines (amphetamines and methamphetamine-like cathinones), entactogens predominantly enhance serotonin release (phenylpiperazines, aminoindanes, para-substituted amphetamines, and MDMA-like cathinones) similar to MDMA (ecstasy), and hallucinogens (tryptamines, hallucinogenic phenethylamines) are direct agonists at serotonergic 5-HT2A receptors. Synthetic cannabinoids are another group of novel substances which all act as agonists at the cannabinoid CB1 receptor similar to THC but are chemically diverse. In particular, the relative serotonergic vs dopaminergic activity (determined by the dopamine/serotonin transporter inhibition ratio in vitro) can be helpful to predict the desired psychotropic but also the toxic effects of novel substances as well as their potential for addiction. Although the use of novel psychoactive substances mostly produces minor or moderate poisonings, serious complications occur. Serotonergic drugs (entactogens and hallucinogens) are associated with acute serotonin syndrome, hyperthermia, seizures, and hyponatremia. Dopaminergic drugs are highly addictive and acute toxicity includes prolonged stimulation, insomnia, agitation, and psychosis. Agitation, anxiety, paranoia, hypertension, and rarely myocardial infarction and renal failure are seen with synthetic cannabinoids. Treatment is supportive.
Similar articles
-
Monoamine transporter and receptor interaction profiles of novel psychoactive substances: para-halogenated amphetamines and pyrovalerone cathinones.Eur Neuropsychopharmacol. 2015 Mar;25(3):365-76. doi: 10.1016/j.euroneuro.2014.12.012. Epub 2015 Jan 5. Eur Neuropsychopharmacol. 2015. PMID: 25624004
-
Clinical toxicology of newer recreational drugs.Clin Toxicol (Phila). 2011 Oct;49(8):705-19. doi: 10.3109/15563650.2011.615318. Clin Toxicol (Phila). 2011. PMID: 21970769 Review.
-
Designer psychostimulants: pharmacology and differences.Neuropharmacology. 2014 Dec;87:59-65. doi: 10.1016/j.neuropharm.2014.01.015. Epub 2014 Jan 20. Neuropharmacology. 2014. PMID: 24456744 Review.
-
Novel psychoactive substances: the pharmacology of stimulants and hallucinogens.Expert Rev Clin Pharmacol. 2016 Jul;9(7):943-54. doi: 10.1586/17512433.2016.1167597. Epub 2016 Apr 4. Expert Rev Clin Pharmacol. 2016. PMID: 26985969 Review.
-
Designer drugs: mechanism of action and adverse effects.Arch Toxicol. 2020 Apr;94(4):1085-1133. doi: 10.1007/s00204-020-02693-7. Epub 2020 Apr 6. Arch Toxicol. 2020. PMID: 32249347 Free PMC article. Review.
Cited by
-
The entactogen 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) as a treatment aid in psychotherapy and its safety concerns.Arch Toxicol. 2024 Aug;98(8):2409-2427. doi: 10.1007/s00204-024-03765-8. Epub 2024 May 14. Arch Toxicol. 2024. PMID: 38743292 Review.
-
Synthetic Cathinones: Epidemiology, Toxicity, Potential for Abuse, and Current Public Health Perspective.Brain Sci. 2024 Mar 29;14(4):334. doi: 10.3390/brainsci14040334. Brain Sci. 2024. PMID: 38671986 Free PMC article. Review.
-
Recurrent Psychotic Episodes Induced by Synthetic Cathinones in a Monozygotic Twin with Drug Addiction: A Case Report.Consort Psychiatr. 2023 Dec 22;4(4):58-65. doi: 10.17816/CP13619. Consort Psychiatr. 2023. PMID: 38618640 Free PMC article.
-
Real-time fluorescent monitoring of phase I xenobiotic-metabolizing enzymes.RSC Adv. 2024 Mar 15;14(13):8837-8870. doi: 10.1039/d4ra00127c. eCollection 2024 Mar 14. RSC Adv. 2024. PMID: 38495994 Free PMC article. Review.
-
Pharmaco-Toxicological Effects of Atypical Synthetic Cathinone Mephtetramine (MTTA) in Mice: Possible Reasons for Its Brief Appearance over NPSs Scene.Brain Sci. 2023 Jan 18;13(2):161. doi: 10.3390/brainsci13020161. Brain Sci. 2023. PMID: 36831704 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources